CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 135 filers reported holding CRISPR THERAPEUTICS AG in Q1 2018. The put-call ratio across all filers is 3.59 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $105,034 | -21.4% | 1,945 | -0.8% | 0.00% | -33.3% |
| Q1 2024 | $133,594 | +12.2% | 1,960 | +3.0% | 0.00% | 0.0% |
| Q4 2023 | $119,065 | +23.5% | 1,902 | -10.5% | 0.00% | 0.0% |
| Q3 2023 | $96,408 | -9.0% | 2,124 | +12.5% | 0.00% | 0.0% |
| Q2 2023 | $105,992 | +23.0% | 1,888 | -0.9% | 0.00% | +50.0% |
| Q1 2023 | $86,175 | +27.6% | 1,905 | +14.7% | 0.00% | 0.0% |
| Q4 2022 | $67,520 | -48.8% | 1,661 | -18.0% | 0.00% | -60.0% |
| Q3 2022 | $132,000 | +22.2% | 2,025 | +14.3% | 0.01% | +25.0% |
| Q2 2022 | $108,000 | -5.3% | 1,772 | -2.0% | 0.00% | +33.3% |
| Q1 2022 | $114,000 | +103.6% | 1,809 | +144.5% | 0.00% | +50.0% |
| Q4 2021 | $56,000 | -46.7% | 740 | -20.9% | 0.00% | -50.0% |
| Q3 2021 | $105,000 | -72.7% | 935 | -60.5% | 0.00% | -73.3% |
| Q2 2021 | $384,000 | +28.0% | 2,370 | -3.7% | 0.02% | +15.4% |
| Q1 2021 | $300,000 | +114.3% | 2,460 | +168.9% | 0.01% | +85.7% |
| Q4 2020 | $140,000 | +109.0% | 915 | +14.4% | 0.01% | +75.0% |
| Q3 2020 | $67,000 | +4.7% | 800 | -7.5% | 0.00% | 0.0% |
| Q2 2020 | $64,000 | +60.0% | 865 | -8.0% | 0.00% | +33.3% |
| Q1 2020 | $40,000 | -2.4% | 940 | +41.4% | 0.00% | 0.0% |
| Q4 2019 | $41,000 | +51.9% | 665 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $27,000 | -12.9% | 665 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $31,000 | +29.2% | 665 | -2.9% | 0.00% | +50.0% |
| Q1 2019 | $24,000 | +41.2% | 685 | +14.2% | 0.00% | 0.0% |
| Q4 2018 | $17,000 | -83.3% | 600 | -73.9% | 0.00% | -80.0% |
| Q3 2018 | $102,000 | -26.1% | 2,300 | -2.1% | 0.01% | -33.3% |
| Q2 2018 | $138,000 | +187.5% | 2,350 | +123.8% | 0.02% | +150.0% |
| Q1 2018 | $48,000 | – | 1,050 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
| Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
| EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
| NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
| ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
| NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
| Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
| Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |